Skip to content

Peri Kasai Portoenterostomy Anchoring of the Jejunal Loop

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04961034
Enrollment
26
Registered
2021-07-14
Start date
2015-01-31
Completion date
2023-12-20
Last updated
2022-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Atresia

Keywords

biliary atresia, kasai portoenterostomy, modified, cholangitis

Brief summary

the study of the effect o the hanging of the jejunal loop to the peri KPE Glisson capsule on the rate of bile drainage and requirement of liver transplantation

Detailed description

To evaluate the effect of anchoring jejunal loop to Glisson capsule of liver after completion of modified Kasai portoenterostomy (KPE) on the frequency of attacks of cholangitis and the overall incidence of native liver survival. Methods: Retrospective study included 29 infants diagnosed as biliary atresia (BA). They were subjected to modified KPE. Two subgroups were present. Group A included 16 infants and had KPE. Group B included 13 infants and had the assumed modification. Wider dissection of fibrous portal plate was considered in both groups. After completion of KPE, the jejunal loop anchored to Glisson capsule of liver at porta hepatis in group B.

Interventions

surgical creation of stoma between porta hepatis and jejunal loop

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Weeks to 8 Weeks
Healthy volunteers
No

Inclusion criteria

* infants with biliary atresia diagnosed and treated before 60th day of age

Exclusion criteria

* infants older than 60 days

Design outcomes

Primary

MeasureTime frameDescription
the total number of cholangitistwo yearsthe total attacks of chollangitis
number of native liver survivorstwo yearsthe decrease of the need of liver transplantation in children with biliary atresia

Secondary

MeasureTime frameDescription
early improvement of liver functions6 monthsnormalization of liver function

Countries

Egypt

Contacts

Primary ContactMohammad Khirallah
mohamed.khirallah@med.tanta.edu.eg+201003546853

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026